Clinical Trials Directory

Trials / Completed

CompletedNCT05051631

BRAVE Strategy - Breast Cancer Risk Assessment -achieVing Equity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,071 (actual)
Sponsor
Vanderbilt University Medical Center · Academic / Other
Sex
Female
Age
25 Years – 49 Years
Healthy volunteers
Accepted

Summary

The central goal of this study is to test strategies to implement evidence-based breast cancer risk assessment in healthcare clinics in Tennessee. The BRAVE Strategy (Breast cancer Risk Assessment - achieVing Equity) study aims to assess the feasibility, reach, acceptability, and appropriateness of select customized strategies to increase uptake of breast cancer risk assessment. The investigators will achieve these aims through a conducting a stepped-wedge trial conducted in 10 healthcare clinics in the state of Tennessee. The primary outcome is the proportion of women age 25-49 having risk assessment. Secondary outcomes include the numbers of 1) women identified as high-risk; 2) pursuing risk-adherent screening; and 3) diagnosed with breast cancer.

Conditions

Interventions

TypeNameDescription
OTHERIntervention plus 12 months maintenanceThe intervention will include 2 months of data collection in the control period, 4 months of education and awareness training, and 12 months of data collection in the maintenance time period.
OTHERIntervention plus 10 months maintenanceThe intervention will include 4 months of data collection in the control period, 4 months of education and awareness training, and 10 months of data collection in the maintenance time period.
OTHERIntervention plus 8 months maintenanceThe intervention will include 6 months of data collection in the control period, 4 months of education and awareness training, and 8 months of data collection in the maintenance time period.
OTHERIntervention plus 6 months maintenanceThe intervention will include 8 months of data collection in the control period, 4 months of education and awareness training, and 6 months of data collection in the maintenance time period.
OTHERIntervention plus 4 months maintenanceThe intervention will include 10 months of data collection in the control period, 4 months of education and awareness training, and 4 months of data collection in the maintenance time period.

Timeline

Start date
2022-03-09
Primary completion
2024-08-30
Completion
2024-08-30
First posted
2021-09-21
Last updated
2025-08-28
Results posted
2025-08-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05051631. Inclusion in this directory is not an endorsement.